Type 2 diabetes mellitus, glycaemic control, associated therapies and risk of rheumatoid arthritis: a retrospective cohort study.
Dawit T ZemedikunKrishna GokhaleJoht Singh ChandanJennifer CooperJanet M LordAndrew FilerMarie FalaheeKrishnarajah NirantharakumarKarim RazaPublished in: Rheumatology (Oxford, England) (2022)
There is a reduced risk of RA in patients with T2DM that may be attributable to the use of statins.